Skip to content
healthcare.dev
Get a free key

LENMELDY

NDC 83222-0200, atidarsagene autotemcel, suspension, from Orchard Therapeutics (Europe) Ltd.

Product NDC
83222-0200
Status
Listed
Labeler
Orchard Therapeutics (Europe) Ltd
Dosage form
SUSPENSION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125758
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83222-0200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATIDARSAGENE AUTOTEMCEL11800000 1/1
Package NDCNDC-11Package
83222-0200-1832220200011 SUSPENSION in 1 BAG (83222-0200-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83222-0200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83222-0200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83222-0200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.